"Lifepoint": a case study in using social science community identification data to guide the implementation of a needle exchange program. NLM AIDSLINE Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


"Lifepoint": a case study in using social science community identification data to guide the implementation of a needle exchange program.

AIDS Educ Prev. 1999 Jun;11(3):187-202. Unique Identifier : AIDSLINE MED/99335768
Somlai AM; Kelly JA; Otto-Salaj L; Nelson D; Department of Psychiatry and Behavioral Medicine, Medical College; of Wisconsin 53226, USA.


Abstract: The public health benefits of needle exchange programs (NEPs) are well known. NEPs lower risk factors for HIV transmission by providing injection drug users (IDUs) with clean syringes and needles; harm reduction materials; and referrals to drug, sexually transmitted disease, mental health, and medical treatment facilities. While exchange programs continue to be implemented, there have been few reports illustrating how social science and community assessment research can be used to guide the development of NEPs. Using the Lifepoint needle exchange program in Milwaukee as a case study, this paper shows how social science methods can be used to understand IDU culture through the community identification process, link qualitative and observational findings to program decision making, and guide the implementation and operation of a needle exchange. The community identification process showed that there were different IDU subcultures in the city indicating that the NEP would need to be tailored to meet the distinctive needs of multiple drug use networks. Ethnographic field observations and key informant and systems representative interviews resulted in a two-stage NEP planning process that included a community task force on IDUs and of the development of methods to operationalize community assessment findings into the operating plan of the NEP. This process illustrates the importance of integrating a systematic community analysis in the planning of a NEP.
Keywords: JOURNAL ARTICLE Acquired Immunodeficiency Syndrome/PREVENTION & CONTROL/ TRANSMISSION Adult Comparative Study *Consumer Participation Costs and Cost Analysis Ethnic Groups Female Human HIV Infections/*PREVENTION & CONTROL/TRANSMISSION Infant, Newborn Male Needle Sharing *Needle-Exchange Programs/ECONOMICS/ORGANIZATION & ADMIN Research Risk Factors Sex Factors *Social Sciences Substance Abuse, Intravenous/COMPLICATIONS Support, U.S. Gov't, P.H.S. WisconsinKWDjournalarticleacquiredimmunodeficiencysyndrome/prevention&control/transmissionadultcomparativestudyKWDconsumerparticipationcostsandcostanalysisethnicgroupsfemalehumanhivinfections/KWDprevention&control/transmissioninfant,newbornmaleneedlesharingKWDneedle-exchangeprograms/economics/organization&adminresearchriskfactorssexfactorsKWDsocialsciencessubstanceabuse,intravenous/complicationssupport,uKWDsKWDgov't,pKWDhKWDsKWDwisconsin
991130
A99B1077

Copyright © 1999 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .